Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation
- PMID: 6117535
- DOI: 10.1159/000468470
Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation
Abstract
A mesolimbic denervation, caused by bilateral intra-accumbens 6-hydroxydopamine, increased the potency of apomorphine in two behavioural tests of dopamine agonist activity, climbing behaviour and circling (combinations of the accumbens denervation with unilateral electrolesion of the striatum). Of a number of neuroleptics tested, haloperidol, fluphenazine, sultopride, tiapride, sulpiride and thioridazine, only the latter two showed greater effectiveness than normal to antagonize the apomorphine responses after mesolimbic denervation. Sulpiride and thioridazine cause remarkably little change in 'normal' tests for antipsychotic activity; their effectiveness in the clinic may reflect a more unique ability to act on dopamine receptor mechanisms of changed sensitivity.
Similar articles
-
The mesolimbic system, denervation and the climbing response in the mouse.Eur J Pharmacol. 1980 Aug 29;66(2-3):207-15. doi: 10.1016/0014-2999(80)90144-2. Eur J Pharmacol. 1980. PMID: 6108225
-
Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):29-35. doi: 10.1007/BF00518775. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6433208
-
Use of the intracerebral injection technique to elucidate mechanisms of apomorphine climbing and its antagonism in the mouse.Psychopharmacology (Berl). 1981;73(1):91-4. doi: 10.1007/BF00431110. Psychopharmacology (Berl). 1981. PMID: 6785798
-
Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.Psychopharmacology (Berl). 1985;85(3):323-8. doi: 10.1007/BF00428196. Psychopharmacology (Berl). 1985. PMID: 2860688
-
A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.Eur J Pharmacol. 1976 Nov;40(1):9-19. doi: 10.1016/0014-2999(76)90348-4. Eur J Pharmacol. 1976. PMID: 791660
Cited by
-
Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.Drugs Aging. 1993 Sep-Oct;3(5):460-78. doi: 10.2165/00002512-199303050-00007. Drugs Aging. 1993. PMID: 8241609 Review.
-
Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.Drugs. 1994 Jun;47(6):1010-32. doi: 10.2165/00003495-199447060-00009. Drugs. 1994. PMID: 7521826 Review.
-
Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.Naunyn Schmiedebergs Arch Pharmacol. 1984 Feb;325(2):93-101. doi: 10.1007/BF00506188. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6425703